Cresco Labs (CRLBF) Assets Average (2021 - 2026)
Cresco Labs (CRLBF) posted Assets Average of $1.2 billion for Q1 2026, down 3.29% on a QoQ basis from $1.2 billion in Q4 2025, and down 11.89% year-over-year from $1.4 billion in Q1 2025.
Cresco Labs (CRLBF) Assets Average (2021 - 2026) Analysis & Trends
Cresco Labs' Assets Average history runs 6 years deep, the most recent figure standing at $1.2 billion for Q1 2026.
- Quarterly Assets Average fell 11.89% year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 11.89% YoY) and the FY2025 annual result came in at $1.3 billion, down 5.94% from the prior year.
- Assets Average was $1.2 billion for Q1 2026 at Cresco Labs, down from $1.2 billion in the prior quarter.
- Across five years, Assets Average topped out at $1.8 billion in Q1 2022 and bottomed at $1.2 billion in Q1 2026.
- A 5-year average of $1.5 billion and a median of $1.4 billion in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average jumped 35.07% — and 2023, when it dropped 17.44%.
- Cresco Labs' Assets Average stood at $1.7 billion in 2022, then retreated by 17.44% to $1.4 billion in 2023, then retreated by 0.7% to $1.4 billion in 2024, then dropped by 9.52% to $1.2 billion in 2025, then decreased by 3.29% to $1.2 billion in 2026.
- Business Quant data shows CRLBF's Assets Average at $1.2 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.3 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | 1.20 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Bn |
| Dec 31, 2025 | 1.24 Bn |
| Sep 30, 2025 | 1.31 Bn |
| Jun 30, 2025 | 1.36 Bn |
| Mar 31, 2025 | 1.36 Bn |
| Dec 31, 2024 | 1.37 Bn |
| Sep 30, 2024 | 1.37 Bn |
| Jun 30, 2024 | 1.36 Bn |
| Mar 31, 2024 | 1.36 Bn |
| Dec 31, 2023 | 1.38 Bn |
| Sep 30, 2023 | 1.46 Bn |
| Jun 30, 2023 | 1.53 Bn |
| Mar 31, 2023 | 1.57 Bn |
| Dec 31, 2022 | 1.67 Bn |
| Sep 30, 2022 | 1.73 Bn |
| Jun 30, 2022 | 1.74 Bn |
| Mar 31, 2022 | 1.78 Bn |
| Dec 31, 2021 | 1.68 Bn |
| Mar 31, 2021 | 1.32 Bn |